Search results
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu...
Fortune via Yahoo Finance· 4 hours agoThough mRNA vaccines could be made much faster—“in the order of three months” to generate a...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoBut in newborns and older adults it can be serious or even deadly. Moderna will rival Pfizer and...
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 4 days agoOn Thursday, Argus increased its price target on Moderna (NASDAQ:MRNA) shares listed on NASDAQ:MRNA...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Gateway - Quartz
Quartz· 6 days agoA new study found that Novo Nordisk’s nearly $1,000 per month diabetes medication Ozempic can be produced for less than $5 a month. Novo Nordisk and Johnson & Johnson both announced billion-dollar ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 5 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
Los Angeles Times· 5 days agoRasmussen Reports used to be a fairly creditable and credible political polling organization, good...
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Zacks via Yahoo Finance· 4 days agoIntra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...